Plants as alternative systems for production oil vaccines

被引:18
作者
Chichester, Jessica A. [1 ]
Yusibov, Vidadi [1 ]
机构
[1] Fraunhofer USA Ctr Mol Biotechnol, Newark, DE 19711 USA
来源
HUMAN VACCINES | 2007年 / 3卷 / 04期
关键词
plant-based expression; plant viruses; subunit vaccines; anthrax; plague;
D O I
10.4161/hv.3.4.4148
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Subunit vaccine production is typically associated with bacterial, yeast, insect or mammalian cell culture systems. Plants, however, are emerging as an alternative platform for producing vaccine antigens, and offer some advantages over other recombinant systems. In particular, plant virus-based transient expression systems are suitable for rapid engineering, ease of scale-up and cost-effective production of target antigens. In addition, this system provides an ideal approach for producing large quantities of vaccine antigens in a short period of time, which is particularly important when faced with natural outbreaks or accidental or intended release of bio-threat agents such as Bacillus anthrax and Yersinia pestis. This commentary reviews the production and evaluation of antigens made in plants in an attempt to develop vaccines against B. anthracis and Y pestis.
引用
收藏
页码:146 / 148
页数:3
相关论文
共 31 条
[1]   Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice [J].
Alvarez, ML ;
Pinyerd, HL ;
Crisantes, JD ;
Rigano, MM ;
Pinkhasov, J ;
Walmsley, AM ;
Mason, HS ;
Cardineau, GA .
VACCINE, 2006, 24 (14) :2477-2490
[2]  
[Anonymous], 1996, MMWR Recomm Rep, V45, P1
[3]   Transformation of an edible crop with the pagA gene of Bacillus anthracis [J].
Aziz, MA ;
Sikriwal, D ;
Singh, S ;
Jarugula, S ;
Kumar, PA ;
Bhatnagar, R .
FASEB JOURNAL, 2005, 19 (09) :1501-+
[4]   Expression of protective antigen in transgenic plants: a step towards edible vaccine against anthrax [J].
Aziz, MA ;
Singh, S ;
Kumar, PA ;
Bhatnagar, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 299 (03) :345-351
[5]   Advances in alfalfa mosaic virus-mediated expression of anthrax antigen in planta [J].
Brodzik, R ;
Bandurska, K ;
Deka, D ;
Golovkin, M ;
Koprowski, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 338 (02) :717-722
[6]  
CHICHESTER JA, 2007, IN PRESS VACCINE
[7]  
Daniell Henry, 2006, Biotechnology Journal, V1, P1071, DOI 10.1002/biot.200600145
[8]   Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine [J].
Heath, DG ;
Anderson, GW ;
Mauro, JM ;
Welkos, SL ;
Andrews, GP ;
Adamovicz, J ;
Friedlander, AM .
VACCINE, 1998, 16 (11-12) :1131-1137
[9]   Plant-based production of xenogenic proteins [J].
Hood, EE ;
Jilka, JM .
CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (04) :382-386
[10]   Human-derived, plant-produced monoclonal antibody for the treatment of anthrax [J].
Hull, AK ;
Criscuolo, CJ ;
Mett, V ;
Groen, H ;
Steeman, W ;
Westra, H ;
Chapman, G ;
Legutki, B ;
Baillie, L ;
Yusibov, V .
VACCINE, 2005, 23 (17-18) :2082-2086